GL-251

N/A

Report date: 2025/01/26 15:41:27
NME

Base Information

Drug NameGL-251
Drug Alias NamesiRNA agent (Genisphere)GL-251
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionELAV-like protein 1 inhibitors
TargetsELAV-like protein 1
Therapy Area/IndicationsOvarian NeoplasmsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGenisphere
China Registration ClassN/A

Develop Information

Active CompaniesGenisphere
Inactive CompaniesN/A
Active IndicationsOvarian NeoplasmsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A